BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 8105618)

  • 1. alpha-Amino-n-butyric acid methyl ester induces concentrative uptake of L-dopa in human Langerhans' cells normally not operative for L-dopa transport.
    Falck B; Andersson L; Mikulowska A; Ronquist G
    Acta Derm Venereol; 1993 Jun; 73(3):197-9. PubMed ID: 8105618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mediated exodus of L-dopa from human epidermal Langerhans cells.
    Falck B; Bendsoe N; Ronquist G
    Amino Acids; 2004 Mar; 26(2):133-8. PubMed ID: 15042441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a new amino acid transport system in human epidermal Langerhans cells: the L-dopa influx/efflux cycle.
    Bendsöe N
    Ups J Med Sci; 2003; 108(3):161-92. PubMed ID: 15000456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functionally different Langerhans' cells in human epidermis.
    Warfvinge K; Mikulowska A; Falck B
    Acta Derm Venereol; 1991; 71(5):429-30. PubMed ID: 1684473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New mechanism for amino acid influx into human epidermal Langerhans cells: L-dopa/proton counter-transport system.
    Falck B; Bendsoe N; Ronquist G
    Exp Dermatol; 2003 Oct; 12(5):602-9. PubMed ID: 14705800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the L-dopa transport system in human epidermal Langerhans cells by omeprazole and its analogues.
    Bendsoe N; Ronquist G
    Amino Acids; 2004 Feb; 26(1):19-26. PubMed ID: 14752612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro uptake of L-dopa and catecholamines into the epidermal Langerhans cell.
    Axelsson S; Elofsson R; Falck B; Sjöborg S
    Acta Derm Venereol Suppl (Stockh); 1978; 58(79):31-5. PubMed ID: 278443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apical and basolateral 4F2hc and the amino acid exchange of L-DOPA in renal LLC-PK1 cells.
    Soares-da-Silva P; Serrão MP
    Amino Acids; 2005 Nov; 29(3):213-9. PubMed ID: 16136276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High- and low-affinity transport of L-leucine and L-DOPA by the hetero amino acid exchangers LAT1 and LAT2 in LLC-PK1 renal cells.
    Soares-da-Silva P; Serrão MP
    Am J Physiol Renal Physiol; 2004 Aug; 287(2):F252-61. PubMed ID: 15271688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of L-DOPA transport in cultured rat and mouse astrocytes.
    Tsai MJ; Lee EH
    J Neurosci Res; 1996 Feb; 43(4):490-5. PubMed ID: 8699535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular mechanism of intestinal levodopa absorption and its possible implications for the treatment of Parkinson's disease.
    Camargo SM; Vuille-dit-Bille RN; Mariotta L; Ramadan T; Huggel K; Singer D; Götze O; Verrey F
    J Pharmacol Exp Ther; 2014 Oct; 351(1):114-23. PubMed ID: 25073474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of radioiodinated 6-iodo-L-DOPA as a cerebral L-amino acid transport marker.
    Kawai K; Ohta H; Kubodera A; Channing MA; Eckelman WC
    Nucl Med Biol; 1996 Apr; 23(3):251-5. PubMed ID: 8782233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-DOPA (L-3,4-dihydroxyphenylalanine) uptake by human red blood cells.
    Floud A; Fahn S
    Biochim Biophys Acta; 1981 Jul; 645(2):165-9. PubMed ID: 7272286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dopamine precursor L-dihydroxyphenylalanine is transported by the amino acid transporters rBAT and LAT2 in renal cortex.
    Quiñones H; Collazo R; Moe OW
    Am J Physiol Renal Physiol; 2004 Jul; 287(1):F74-80. PubMed ID: 15180924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and gene silencing of LAT2, the L-3,4-dihydroxyphenylalanine (L-DOPA) transporter, in pig renal LLC-PK1 epithelial cells.
    Soares-Da-Silva P; Serrão MP; Pinho MJ; Bonifácio MJ
    FASEB J; 2004 Oct; 18(13):1489-98. PubMed ID: 15466357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of apical transporter of L-DOPA in human intestinal Caco-2 cells.
    Fraga S; Sampaio-Maia B; Serrão MP; Soares-da-Silva P
    Acta Physiol Scand; 2002 Jun; 175(2):103-11. PubMed ID: 12028130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between the L-DOPA histofluorescence procedure and the indirect immunofluorescence with anti-T6 and -HLA-DR monoclonal antibodies in visualizing Langerhans cells of human epidermis.
    Crivellato E; Damiani D; Mallardi F
    Acta Histochem; 1990; 88(1):59-64. PubMed ID: 2113342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular modulation of inward and outward apical transporters of L-dopa in LLC-PK(1) cells.
    Soares-Da-Silva P; Serrão MP
    Am J Physiol Renal Physiol; 2000 Oct; 279(4):F736-46. PubMed ID: 10997924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Na+-independent transporters, LAT-2 and b0,+, exchange L-DOPA with neutral and basic amino acids in two clonal renal cell lines.
    Gomes P; Soares-da-Silva P
    J Membr Biol; 2002 Mar; 186(2):63-80. PubMed ID: 11944084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous boluses and continuous infusions of L-dopa methyl ester in fluctuating patients with Parkinson's disease.
    Stocchi F; Ruggieri S; Carta A; Ryatt J; Quinn N; Jenner P; Marsden CD; Agnoli A
    Mov Disord; 1992; 7(3):249-56. PubMed ID: 1620143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.